CXCR1 and its downstream NF-κB inflammation signaling pathway as a key target of Guanxinning injection for myocardial ischemia/reperfusion injury

Guanxinning Injection (GXNI) is used clinically to treat cardiac injury, but its active components and mode of action remains unclear. Therefore, a myocardial ischemia/reperfusion injury (MIRI) model-based integrated strategy including function evaluation, RNA-seq analysis, molecular docking, and ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Guangxu, Liu, Jiaxu, Wang, Huanyi, He, Shuang, Liu, Jianwei, Fan, Guanwei, Lyu, Ming, Zhu, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618804/
https://www.ncbi.nlm.nih.gov/pubmed/36325326
http://dx.doi.org/10.3389/fimmu.2022.1007341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618804/
https://www.ncbi.nlm.nih.gov/pubmed/36325326
http://dx.doi.org/10.3389/fimmu.2022.1007341

Ejemplares similares